XML 19 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
ORGANIZATION
9 Months Ended
Dec. 31, 2011
Organization, Consolidation and Presentation Of Financial Statements [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
NOTE A – ORGANIZATION
 
Boston Capital Tax Credit Fund IV L.P. (the "Fund") was organized under the laws of the State of Delaware as of October 5, 1993, for the purpose of acquiring, holding, and disposing of limited partnership interests in operating partnerships which will acquire, develop, rehabilitate, operate and own newly constructed, existing or rehabilitated low-income apartment complexes ("Operating Partnerships"). Effective as of June 1, 2001 there was a restructuring and, as a result, the Fund's general partner was reorganized as follows. The general partner of the Fund continues to be Boston Capital Associates IV L.P., a Delaware limited partnership. The general partner of the general partner of the Fund is BCA Associates Limited Partnership, a Massachusetts limited partnership, whose sole general partner is C&M Management, Inc., a Massachusetts corporation and whose limited partners are Herbert F. Collins and John P. Manning. Mr. Manning is the principal of Boston Capital Partners, Inc. The limited partner of the general partner of the Fund is Capital Investment Holdings, a general partnership whose partners are various officers and employees of Boston Capital Partners, Inc. and its affiliates. The assignor limited partner is BCTC IV Assignor Corp., a Delaware corporation which is now wholly-owned by John P. Manning.
 
Pursuant to the Securities Act of 1933, the Fund filed a Form S-11 Registration Statement with the Securities and Exchange Commission, effective December 16, 1993, which covered the offering (the "Public Offering") of the Fund's beneficial assignee certificates ("BACs") representing assignments of units of the beneficial interest of the limited partnership interest of the assignor limited partner. The Fund registered 30,000,000 BACs at $10 per BAC for sale to the public in one or more series. On April 18, 1996, an amendment to Form S-11 which registered an additional 10,000,000 BACs for sale to the public in one or more series became effective. On April 2, 1998, an amendment to Form S-11, which registered an additional 25,000,000 BACs for sale to the public in one or more series, became effective. On August 31, 1999, an amendment to Form S-11, which registered an additional 8,000,000 BACs for sale to the public in one or more series, became effective. On July 26, 2000, an amendment to Form S-11, which registered an additional 7,500,000 BACs for sale to the public in one or more series, became effective. On July 24, 2001, an amendment to Form S-11, which registered an additional 7,000,000 BACs for sale to the public in one or more series, became effective. On July 24, 2002, an amendment to Form S–11, which registered an additional 7,000,000 BACs for sale to the public, became effective. On July 1, 2003, an amendment to Form S–11, which registered an additional 7,000,000 BACs for sale to the public, became effective.
 
Below is a summary of the BACs sold and total equity raised, by series, as of the date of this filing:
 
Series
 
Closing Date
 
BACs Sold
   
Equity Raised
 
                     
Series 20
 
June 24, 1994
    3,866,700     $ 38,667,000  
                     
Series 21
 
December 31, 1994
    1,892,700     $ 18,927,000  
                     
Series 22
 
December 28, 1994
    2,564,400     $ 25,644,000  
                     
Series 23
 
June 23, 1995
    3,336,727     $ 33,366,000  
                     
Series 24
 
September 22, 1995
    2,169,878     $ 21,697,000  
                     
Series 25
 
December 29, 1995
    3,026,109     $ 30,248,000  
                     
Series 26
 
June 25, 1996
    3,995,900     $ 39,959,000  
                     
Series 27
 
September 17, 1996
    2,460,700     $ 24,607,000  
                     
Series 28
 
January 29, 1997
    4,000,738     $ 39,999,000  
  
Series
 
Closing Date
 
BACs Sold
   
Equity Raised
 
                 
Series 29
 
June 10, 1997
    3,991,800     $ 39,918,000  
                     
Series 30
 
September 10, 1997
    2,651,000     $ 26,490,750  
                     
Series 31
 
January 18, 1998
    4,417,857     $ 44,057,750  
                     
Series 32
 
June 23, 1998
    4,754,198     $ 47,431,000  
                     
Series 33
 
September 21, 1998
    2,636,533     $ 26,362,000  
                     
Series 34
 
February 11, 1999
    3,529,319     $ 35,273,000  
                     
Series 35
 
June 28, 1999
    3,300,463     $ 33,004,630  
                     
Series 36
 
September 28, 1999
    2,106,837     $ 21,068,375  
                     
Series 37
 
January 28, 2000
    2,512,500     $ 25,125,000  
                     
Series 38
 
July 31, 2000
    2,543,100     $ 25,431,000  
                     
Series 39
 
January 31, 2001
    2,292,152     $ 22,921,000  
                     
Series 40
 
July 31, 2001
    2,630,256     $ 26,269,256  
                     
Series 41
 
January 31, 2002
    2,891,626     $ 28,916,260  
                     
Series 42
 
July 31, 2002
    2,744,262     $ 27,442,620  
                     
Series 43
 
December 31, 2002
    3,637,987     $ 36,379,870  
                     
Series 44
 
April 30, 2003
    2,701,973     $ 27,019,730  
                     
Series 45
 
September 16, 2003
    4,014,367     $ 40,143,670  
                     
Series 46
 
December 19, 2003
    2,980,998     $ 29,809,980  
 
The Fund concluded its public offering of BACs in the Fund on December 19, 2003.